Papanek Julie Grant, Director at Day One Biopharmaceuticals, Inc. (DAWN), sold 1,242 shares at $20.00 ($25K) on 2022-07-08, disclosed to the SEC on 2022-07-12.
Scheduled sale ($25k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| DAWN | SELL | 2022-08-08 | $200K | — | Filing → |
| DAWN | SELL | 2022-07-20 | $52K | — | Filing → |
| DAWN | SELL | 2022-07-12 | $36K | — | Filing → |